- 商品介绍
- 规格参数
- 包装参数
General description
A cell-permeable isoxazolyl-benzamide compound that is more effective than NSC23766 (Cat. Nos. 553502 & 553508) in inhibiting PDGF-BB- (Cat. No. 521225) induced cellular Rac1 activation (45.8% vs 11.1% inhibition by 4 h pretreatment of the respective compound at 50 µM) in serum-starved SMCs (human aortic smooth muscle cells) by interfering Rac1-Tiam1 interaction, while exhibiting no effect toward cellular Cdc42 and RhoA activation or Rac1 interaction to its effector Pak1. Shown to effectively prevent PDGF-BB-induced membrane ruffling and lamellipodia formation in serum-starved 3T3 cells (4 h pretreatment at 25 µM). The solid form of this compound (Cat. No. 553511" target="_blank">553511) is also available.
Packaging
Packaged under inert gas
Physical form
A 100 mM (10 mg/241 µl) solution of Rac1 Inhibitor II, Z62954982 (Cat. No. 553511) in DMSO
Preparation Note
Following initial thaw, aliquot and freeze (-20°C).
Other Notes
Ferri, N., et al. 2009. J. Med. Chem.52, 4087.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Irritant (B)
| Quality Segment | 100 |
| assay | ≥93% (HPLC) |
| form | liquid |
| manufacturer/tradename | Calbiochem® |
| storage condition | OK to freeze,avoid repeated freeze/thaw cycles,desiccated (hygroscopic),protect from light |
| shipped in | ambient |
| storage temp. | −20°C |
| SMILES string | CC1=CC=C(NC(C2=CC(OCC3=C(C)ON=C3C)=CC=C2)=O)C=C1S(N)(=O)=O |
| InChI | 1S/C20H21N3O5S/c1-12-7-8-16(10-19(12)29(21,25)26)22-20(24)15-5-4-6-17(9-15)27-11-18-13(2)23-28-14(18)3/h4-10H,11H2,1-3H3,(H,22,24)(H2,21,25,26) |
| InChI key | OZZQJOAJXMUXCO-UHFFFAOYSA-N |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
询价
-
¥ 1148.92
-
询价
-
询价
-
询价
-
¥ 2068.25
-
¥ 4039.86
-
¥ 8293.41
-
询价
-
¥ 6894.69
-
询价
-
询价
-
询价
-
¥ 3812.28
-
¥ 15214.65
-
¥ 1568.60
-
¥ 2842.54
-
¥ 2617.87
-
¥ 2307.00
-
¥ 1476.40
微信小程序
7X24小时在线咨询